search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
infection control & hospital epidemiology july 2018, vol. 39, no. 7 commentary


Human Factors and Systems Engineering: The Future of Infection Prevention?


Priti R. Patel, MD, MPH, Alexander J. Kallen, MD, MPH


(See article by Leback et al, pages 841-848.) Human factors is a discipline that utilizes the “under-


standing of interactions among humans and other elements of a system” and methods and design principles to “optimize the human well-being and overall system performance.”1 The field traces its origins to the study and design of human operator use of military systems and equipment.2 Human factors approa- ches to certain subtopics such as accidents, human error, and warning systems have been used to improve safety in industries including aviation, aerospace, transportation, and mining. The same principles and methods can also be applied to improving safety in healthcare systems, particularly as new technologies are incorporated into healthcare delivery, in the form of medical and surgical devices, health informatics, electronic medical record clinical decision supports, and health monitoring devices. In this issue, Leback et al3 describe results of injection-


safety–focused observations and interviews conducted in a range of outpatient clinical settings within a single health system. Challenges to basic injection safety standards (eg, syringe reuse for >1 patient) persist in many healthcare settings,3,4 necessitating a thorough understanding of barriers to safe practices and innovative approaches to overcome such barriers, especially in outpatient clinics. Clinics in this study included adult and pediatric primary-care clinics, dialysis centers, urgent care clinics, imaging clinics, and outpatient procedure clinics. Observations of injection practices were conducted, and interviews of staff were also performed to understand barriers and facilitators to injection safety in the clinics. The authors utilized a human factors approach to evaluate interview responses and connected themes to the observation data. The Systems Engineering Initiative for Patient Safety (SEIPS)5 framework was used to design inter- view questions and classify barriers and facilitators into the SEIPS categories of: workflow, persons, organization, envir- onment, and tools and technology. This study contributes several pertinent findings. First,


generally good adherence to recommended safe injection practices was observed across clinics, including proper use of single dose vials (ie, 1-time use for 1 patient only). However,


opportunities for improvement were identified, such as keep- ing multidose vials out of patient care areas and cleansing septa of vials prior to accessing. Second, according to the authors, the observations conducted in the study uncovered a greater number of gaps compared to routine infection prevention site visits of these same clinics that have relied upon self-reports of practice. This finding reinforces the importance of direct observations of practice as part of on-site assessments, which is a component of the CDC Guide to Infection Prevention in Outpatient Settings6 and is essential to any evaluation of infection control practice. Third, and perhaps most enlightening, is the analysis of the interview responses. For most SEIPS categories, roughly half of responses were coded as barriers. The exception was the tools and technologies category, for which only 27% of responses were barriers. All barriers were specifically reported as ones that make it difficult to give injections safely. The most frequently reported barrier, in any category, to giving safe injections was feeling rushed or high patient turnover. While perhaps not surprising, it should be alarming that staff across different clinic types reported this pervasive issue that has such potential to cause medical errors. Important barriers related to the environment were small patient-care areas and medication rooms, and an excessive distance between these 2 areas. Notable facilitators were the availability of injection supplies in work areas, and a commonly reported facilitator in the cate- gory of workflow was preparing medications in advance. The latter is a logical strategy to avoid errors when feeling rushed, yet it is at odds with recommendations to prepare medications as close in time as possible to their administration. This is particularly true if staff are engaging in batch preparation of medications for multiple patients, a practice that has con- tributed to outbreaks of infection.7,8 The Institute for Safe Medication Practices (ISMP) has recommended avoiding the need for vial manipulation and syringe preparation in the clinic setting through the use of manufacturer-prefilled or pharmacy-prepared prefilled syringes for i.v. push medications and flush.9 When available, the use of “ready-to-administer” medications can save time, improve workflow, and reduce opportunities for errors and contamination. In this study, many


Affiliations: Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.


© 2018 by The Society for Healthcare Epidemiology of America. All rights reserved. 0899-823X/2018/3907-0012. DOI: 10.1017/ice.2018.122 Received April 24, 2018; accepted April 28, 2018


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144